ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in ProMIS Neurosciences Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +16 vs. Q4 2025
- Shares held
- 6.14M
- +5.88M (+2,222.2%) vs. Q4 2025
- Total value
- $78.0M
- +$76.2M (+4,237.6%) vs. Q4 2025
- New holders
- 18
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TD Waterhouse Canada Inc. | 5 | $65 | 0.00% | −20−80.0% | Reduced |
| Federation des caisses Desjardins du Quebec | 10 | $127 | 0.00% | −320−97.0% | Reduced |
| Steward Partners Investment Advisory, LLC | 100 | $1.27K | 0.00% | +100 | New |
| Royal Bank of Canada | 268 | $4.00K | 0.00% | +50+22.9% | Added |
| Advisor Group Holdings, Inc. | 360 | $4.57K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,300 | $16.5K | 0.00% | −150−10.3% | Reduced |
| Seven Fleet Capital Management LP | 10,600 | $134.6K | 0.04% | +10,600 | New |
| Boothbay Fund Management, LLC | 16,043 | $203.7K | 0.00% | +16,043 | New |
| Heights Capital Management, Inc | 50,660 | $643.4K | 0.18% | +50,660 | New |
| Ikarian Capital, LLC | 55,000 | $698.5K | 0.10% | +55,000 | New |
| Empery Asset Management, LP | 60,353 | $766.5K | 0.92% | +60,353 | New |
| Millennium Management LLC | 77,921 | $989.6K | 0.00% | +77,921 | New |
| 683 Capital Management, LLC | 92,850 | $1.18M | 0.11% | +92,850 | New |
| ADAR1 Capital Management, LLC | 95,350 | $1.21M | 0.07% | +95,350 | New |
| Adage Capital Partners GP, L.L.C. | 139,275 | $1.77M | 0.00% | +139,275 | New |
| Squadron Capital Management LLC | 324,977 | $4.13M | 1.65% | +324,977 | New |
| Sphera Funds Management Ltd. | 325,591 | $4.14M | 0.71% | +313,784+2,657.6% | Added |
| Fan Yu | 329,760 | $4.19M | 4.32% | +329,760 | New |
| Great Point Partners LLC | 371,402 | $4.72M | 1.16% | +371,402 | New |
| Woodline Partners LP | 395,295 | $5.02M | 0.02% | +395,295 | New |
| Ally Bridge Group (NY) LLC | 414,219 | $5.26M | 5.23% | +164,880+66.1% | Added |
| Trails Edge Capital Partners, LP | 557,103 | $7.08M | 1.67% | +557,103 | New |
| Wellington Management Group LLP | 696,378 | $8.84M | 0.00% | +696,378 | New |
| Deep Track Capital, LP | 835,655 | $10.6M | 0.22% | +835,655 | New |
| Janus Henderson Group PLC | 1,292,757 | $16.4M | 0.01% | +1,292,757 | New |
| Disciplined Equity Management, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −20−100.0% | Sold out |